COHANCE : APPOINTS ABHIMANYU OJHA AS CFO

• Board approved appointment of Mr. Abhimanyu Ojha as Chief Financial Officer and Key Managerial Personnel w.e.f. 12 October 2026 • Mr. Ojha has over two decades of experience across multinational healthcare and pharma companies • Previously Global CFO & President Finance at Intas Pharmaceuticals; earlier senior roles at Viatris (formerly Mylan), Sun Pharmaceuticals and Ranbaxy Laboratories • Umang Vohra (Chairman & Group CEO), Abhimanyu Ojha (CFO) and Sisir K Mishra (Company Secretary) named authorised KMP for materiality disclosures under Regulation 30(5) Impact: Neutral (Administrative leadership change; no financial or operational impact disclosed)

Cohance Lifesciences Limited

Open attachment

← Back to feed